Terminated PHASE2 INTERVENTIONAL NCT00155883

Bi-Weekly Docetaxel Plus 24-Hour Infusion of High-Dose 5-Fluorouracil / Leucovorin (HDFL) for Inoperable Advanced or Metastatic Gastric Cancer

Sponsor: National Taiwan University Hospital

Interventions 5-Fluorouracil Leucovorin Taxteral

Updated 5 times since 2017 Last updated: Aug 14, 2008 Started: Jun 30, 2004 Completion: Jul 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

slow a accrul due to many competitive trials.

Other terminated trials from National Taiwan University Hospital

See all terminations from National Taiwan University Hospital

Other Gastric Cancer trials with similar outcome

Browse all Gastric Cancer trials

This PHASE2 trial investigates Gastric Cancer and is currently terminated or withdrawn. National Taiwan University Hospital leads this study, which shows 5 recorded versions since 2004 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE2

First recorded

Jun 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Taiwan University Hospital

Data source: National Taiwan University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taipei, Taiwan